1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The link for this program now points to a previous cycle.
Historical funding: Not specified
Prior eligibility: Organizations leading multidisciplinary teams, as selected by DARPA. Applicants should confirm final requirements in the official notice before submission.
Next-Generation Nonsurgical Neurotechnology (N3) program is a grant from the Defense Advanced Research Projects Agency (DARPA) that funded the development of high-performance, bi-directional brain-machine interfaces that do not require surgical implantation. The program targeted technology capable of reading from and writing to 16 independent neural channels within a 16mm³ brain volume within 50ms, with applications including control of unmanned aerial vehicles, active cyber defense, and human-computer teaming for complex military missions. Eligible applicants were organizations leading multidisciplinary research teams selected by DARPA. Note: this program is now complete and is preserved for reference only; no active funding is available.
DPA26BZ06-DV023 is a Direct-to-Phase-II SBIR paying $700,000 over 18 months plus a $500,000 option. The physics demands 256x more transmit power than the systems that qualify you to compete, and DARPA will not accept modeling alone as proof. Here is the eligibility wall, the five engineering problems, and who can realistically win it before the October 21 close.
Read articleRelease 6's SBIR topics got the attention. Its three STTR topics — SHIELDER, fuel-flexible electric propulsion, and hypersonic wind tunnel noise diagnostics — are all Direct-to-Phase-II, all require a research institution to perform at least 30 percent of the work, and all close October 21, 2026. The feasibility gates are the real filter.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read article